Concepedia

Catherine Overed-Sayer

CO

6

Publications

212

Citations

6

H-Index

2020

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

AstraZeneca (Sweden)

Catherine Overed-Sayer is an author at AstraZeneca (United Kingdom) specializing in fibrosis, oxidative stress, and gene expression.

ORCID

Top concepts

Publications per year

2020–2023

6

Publications

6

Increased expression and accumulation of GDF15 in IPF extracellular matrix contribute to fibrosis

Agata Radwańska, Christopher T. Cottage, Antonio Piras et al. · JCI Insight · 2022 · 60 citations · Full text

Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects

Catherine Overed-Sayer, Elena Miranda, Rebecca Dunmore et al. · Thorax · 2020 · 37 citations · Full text

De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8

Anindya Roy, Lei Shi, Ashley Chang et al. · Nature Communications · 2023 · 36 citations · Full text

Epithelial senescence in idiopathic pulmonary fibrosis is propagated by small extracellular vesicles

Sabha Asghar, Susan J. Monkley, D Smith et al. · Respiratory Research · 2023 · 29 citations · Full text

Sensitization of the UPR by loss of PPP1R15A promotes fibrosis and senescence in IPF

Susan J. Monkley, Catherine Overed-Sayer, Helen Parfrey et al. · Scientific Reports · 2021 · 26 citations · Full text

, , +21

Rows per page

1–5 of 6